NantHealth Story

NH -- USA Stock

USD 3.90 0.18 4.84%

Macroaxis Story

It looks like Health Catalyst will continue to recover much faster as its share price surged up 5.06% today to NantHealth's 22.4199%. As many rational traders are trying to avoid healthcare space, it makes sense to concentrate on NantHealth a little further and understand how it stands against Health Catalyst and other similar entities. We are going to examine some of the competitive aspects of both NantHealth and Health.

Published over a month ago

View all stories for NantHealth | View All Stories

Will Health Catalyst stockholders switch to NantHealth (NASDAQ:NH)?

By analyzing existing technical indicators between NantHealth and Health, you can compare the effects of market volatilities on both companies' prices and check if they can diversify away market risk if combined in one of your portfolios. You can also utilize pair trading strategies for matching a long position in Health with a short position in NantHealth. Check out our pair correlation module for more information.

Let's begin by analyzing the assets. The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. NantHealth has an asset utilization ratio of 22.24 percent. This implies that the company is making $0.22 for each dollar of assets. An increasing asset utilization means that NantHealth is more efficient with each dollar of assets it utilizes for everyday operations.

Out of tens of thousands of stocks, funds, and ETFs that trade on global exchanges each represent an individual company which you can analyze using comparative analysis. To determine which one of the two companies, such as NantHealth or Health is a better fit for your portfolio, analyzing a few basic fundamental indicators is a good first step.

How important is NantHealth's Liquidity

NantHealth financial leverage refers to using borrowed capital as a funding source to finance NantHealth ongoing operations. It is usually used to expand the firm's asset base and generate returns on borrowed capital. NantHealth financial leverage is typically calculated by taking the company's all interest-bearing debt and dividing it by total capital. So the higher the debt-to-capital ratio (i.e., financial leverage), the riskier the company. Please check the breakdown between NantHealth's total debt and its cash.

Correlation Between NantHealth and Health Catalyst

In general, stock analysis is a method for investors and traders to make individual buying and selling decisions. Stock correlation analysis is also essential because it can help investors realize that they may not be as diversified as they think. Risk management strategies are usually required to make sure all portfolios are properly aligned against their risk tolerance level. You can consider holding NantHealth together with similar or unrelated positions with a negative correlation. For example, you can also add Health Catalyst to your portfolio. If Health Catalyst is not perfectly correlated to NantHealth it will diversify some of the market risks out of the positively correlated stocks in your portfolio. However, the disadvantage of this sort of hedging is that it can potentially affect your investment returns throughout market cycles. When NantHealth for example, for example, performs excellent and delivers stable returns, the negatively correlated position you locked in as a hedge may drag your returns down. Please check pair correlation details between NH and HCAT for more information.

Exercise or conversion by Ronald Louks of 10000 shares of NantHealth subject to Rule 16b-3

Legal trades by NantHealth insiders are very common, as founders, directors, or employees of any publicly traded firm often have stock or stock options. These trades are made public in the United States through the filing of Form 4 of the Securities and Exchange Commission. Below entry was recorded recently and is publicly available as an insider trade:

NantHealth insider trading alert for exercise of restricted stock units by Ronald Louks, Chief Operating Officer, on 18th of October 2020. This event was filed by Nanthealth Inc with SEC on 2018-02-07. Statement of changes in beneficial ownership - SEC Form 4 [view details]

Note, although insider trading is legal, in the United States, Canada, Australia, and Germany, for mandatory reporting purposes, corporate insiders are defined as a company's officers, directors, and any beneficial owners of more than 10% of a class of the company's equity securities.

What is the case for NantHealth Investors

Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include product or services discounts, promotions, as well as early payments on invoices or services rendered in advance.

Revenue Breakdown

Lets now check NantHealth revenue. Based on the latest financial disclosure, NantHealth reported 91.63 M of revenue. This is 98.8% lower than that of the Healthcare sector and significantly higher than that of the Health Information Services industry. The revenue for all United States stocks is 99.03% higher than that of NantHealth. As for Health Catalyst we see revenue of 179.07 M, which is much higher than that of the Health Information Services

	NantHealth	91.63 Million
	Sector	0.0
	Health	179.07 Million

91.6 M

NantHealth

Sector

179.1 M

Health

Another 3 percent rise for NantHealth

Downside variance is down to 22.43. It may hint to a possible volatility drop. As of the 12th of December 2020, NantHealth secures the Downside Deviation of 4.74, risk adjusted performance of 0.1128, and Mean Deviation of 3.91. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of NantHealth, as well as the relationship between them. Strictly speaking, you can use this information to find out if the firm will indeed mirror its model of past prices, or the prices will eventually revert. We have analyze and collected data for nineteen technical drivers for NantHealth, which can be compared to its peers in the industry. Please verify NantHealth standard deviation, maximum drawdown, as well as the relationship between the Maximum Drawdown and expected short fall to decide if NantHealth is priced some-what accurately, providing market reflects its recent price of 3.44 per share. Given that NantHealth has jensen alpha of 0.4619, we recommend you to check NantHealth's last-minute market performance to make sure the company can sustain itself at a future point.

Our Conclusion on NantHealth

While some other firms within the health information services industry are still a little expensive, even after the recent corrections, NantHealth may offer a potential longer-term growth to stockholders. With a somewhat neutral outlook on your 30 days horizon, it may be better to hold off any trading activity and neither pick up new shares of NantHealth nor exit your existing holdings in the Stock. It seems the expected volatility has not yet been fully factored into the current price. Please use our equity advice module to run different scenarios to ensure your current risk level and investment horizon are fully reflective of your current investing preferences in regards to NantHealth.

About Contributor

Vlad Skutelnik is a Macroaxis Contributor. Vlad covers stocks, funds, cryptocurrencies, and ETFs that are traded in North America, focusing primarily on fundamentals, valuation and market volatility. He has many years of experience in fintech, predictive investment analytics, and risk management. View Profile

This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Vlad Skutelnik do not own shares of NantHealth. Please refer to our Terms of Use for any information regarding our disclosure principles.

Would you like to provide feedback on the content of this article?

You can get in touch with us directly or send us a quick note via email to editors@macroaxis.com

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2021 Macroaxis LLC